Bottom line
AIBD vs TZA: the short answer
AIBD (Direxion Daily AI and Big Data Bear 2X ETF) and TZA (Direxion Daily Small Cap Bear 3X ETF) are both etfs.
TZA is cheaper at 0.99% vs 1.05% — a difference of $6.00 a year per $10,000 invested.
Over one year, TZA returned −40.2% vs −48.9% for AIBD.
Updated Nov 19, 2026
AIBD vs TZA side by side
| AIBD | TZA | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.05% | 0.99% |
| Annual cost per $10k | $105 | $99 |
| 10-yr cost on $10k (prospectus) | $2,855 | $1,213 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −48.9% | −40.2% |
| 5-yr return (annualized) | — | −31.4% |
| 10-yr return (annualized) | — | −41.4% |
| Best quarter | +20.6% | +81.1% |
| Worst quarter | −45.8% | −64.3% |
| Net assets (fund) | $7.4M | $233.3M |
| Number of holdings | 7 | 11 |
| Portfolio turnover | % | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | AIBD | TZA | Difference |
|---|---|---|---|
| 2025 | −48.9% | −40.2% | −8.7% |
Source: Fund prospectus bar charts
Holdings overlap
7 of AIBD's top 7 holdings also appear in TZA's top 11.
| Holding | AIBD | TZA |
|---|---|---|
| Dreyfus | 57.21% | 59.72% |
| Dreyfus | 22.25% | 16.20% |
| Goldman Sachs Liq Es Fd A | 16.92% | 8.68% |
| Goldman Financial | 12.18% | 25.11% |
| N/a | 2.92% | -7.37% |
| N/a | 2.81% | -7.37% |
| N/a | -2.18% | -7.37% |
Source: SEC Form N-PORT
AIBD top 10
- Dreyfus — 57.21%
- Dreyfus — 22.25%
- Goldman Sachs Liq Es Fd A — 16.92%
- Goldman Financial — 12.18%
- N/a — 2.92%
- N/a — 2.81%
- N/a — -2.18%
TZA top 10
- Dreyfus — 59.72%
- Goldman Financial — 25.11%
- Dreyfus — 16.20%
- Goldman Sachs Liq Es Fd A — 8.68%
- N/a — 0.54%
- N/a — -0.19%
- N/a — -1.18%
- N/a — -1.28%
- N/a — -1.79%
- N/a — -2.03%
FAQ
What is the difference between AIBD and TZA?
Which is cheaper, AIBD or TZA?
Should I own both AIBD and TZA?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.